LCTX
Lineage Cell Therapeutics Inc
1.00$
+8.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2,100.0% | -1,300.0% | -700.0% | -423.6% | -9,252.9% | -2,112.9% | -550.1% | -117.6% | -223.2% | -156.6% | -108.6% | -118.5% | -106.7% | -221.3% | -210.1% | -312.2% | -1,162.5% | -1,031.4% | -1,996.2% | -1,757.9% | -1,879.5% | -1,703.0% | -2,180.9% | -2,161.5% | -2,555.4% | -604.7% | 7.2% | -319.4% | -243.1% | -130.0% | |
| – | – | – | 5.7% | 143.8% | 194.6% | 130.9% | 145.7% | 152.4% | 0.7% | 2.3% | -18.1% | 1.1% | 1.8% | 25.2% | 54.3% | 167.4% | 138.1% | 432.1% | 250.0% | 211.2% | 183.9% | 231.1% | 203.0% | 263.8% | 22.4% | 4.9% | 7.7% | 6.4% | 4.8% | |
| – | – | – | – | – | – | 49.6% | – | – | 9.9% | – | 14.4% | 8.9% | 25.4% | 17.4% | 28.0% | 75.8% | 112.5% | 228.9% | 436.1% | 353.1% | 219.4% | 381.5% | 242.2% | 288.1% | 90.3% | 29.2% | 51.9% | 53.4% | 32.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -317.9% | -528.1% | -307.1% | -3,568.5% | -946.1% | -5,383.8% | -306.4% | -453.9% | 76.3% | 28.5% | – | – | – | |
| -400.0% | 1,500.0% | 33.3% | 42.4% | -478.4% | -25.4% | 19.2% | 22.6% | 51.4% | 53.8% | 23.2% | 10.2% | 95.9% | -15.9% | -12.2% | 0.6% | 27.6% | 95.3% | -42.5% | 130.4% | -32.9% | 138.3% | 45.1% | -132.3% | 177.6% | 541.8% | 127.0% | -120.8% | -92.3% | -28.2% | |
| 0.0% | 100.0% | 33.3% | 15.6% | 63.6% | 3.4% | 1.0% | 0.0% | 0.0% | 0.0% | 0.9% | 0.6% | 57.2% | 3.2% | 11.8% | 22.1% | 23.7% | 79.6% | 24.8% | 210.5% | 112.2% | 74.0% | 232.1% | 29.8% | 8.3% | 9.1% | 2.8% | 7.5% | 5.9% | 3.6% | |
| – | – | -33.3% | -15.6% | -63.6% | -3.4% | -1.0% | – | – | – | -0.9% | -0.6% | -60.5% | -2.4% | 86.9% | -27.6% | -6.2% | -128.1% | -51.8% | -293.6% | -483.5% | -570.6% | 834.5% | 1,147.3% | 1,686.7% | 250.1% | -313.9% | 519.3% | -24.3% | -92.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 25.3% | 2,430.0% | 2.7% | 3,253.2% | 185.8% | – | 0.4% | – | – | |
| -200.0% | -200.0% | -66.7% | -12.3% | -68.9% | – | – | – | -23.6% | -42.1% | – | – | – | – | – | – | – | 1,226.2% | 3,262.2% | 1,963.3% | 1,465.2% | -49.6% | -17.0% | -7.4% | -3.5% | -1.4% | -0.1% | -0.4% | -0.2% | -0.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 24.2% | 10.1% | 71.6% | 9.6% | -24.6% | -4.7% | 3,185.5% | -0.5% | -0.2% | -0.6% | -0.6% | -0.4% | |
| 1,100.0% | 6,700.0% | 133.3% | 715.2% | 1,745.0% | 2,336.4% | 456.0% | 15.6% | 318.2% | 207.8% | 0.0% | 66.4% | 167.4% | 856.2% | 700.1% | 88.7% | 113.0% | 1,197.6% | 3,268.8% | 2,556.2% | 1,455.7% | 3,091.0% | 407.8% | 41.7% | 3,863.5% | 947.9% | 11.1% | 71.8% | 377.5% | 185.1% | |
| -1,000.0% | 5,400.0% | -566.7% | 276.0% | -7,571.6% | 220.1% | -95.2% | -101.9% | 94.9% | 51.3% | -109.5% | -52.7% | 0.2% | 632.5% | 574.3% | -255.2% | -1,055.1% | 40.0% | 1,232.6% | 502.8% | -894.4% | 823.1% | -938.3% | -967.7% | 2,986.7% | 592.8% | -301.6% | 268.9% | 109.1% | -34.6% | |
| -2,100.0% | -1,300.0% | -700.0% | -439.2% | -9,316.5% | -2,116.3% | -551.1% | -117.6% | -223.2% | -156.6% | -109.5% | -119.1% | -163.9% | -224.5% | -222.0% | -334.2% | -1,186.2% | -1,111.0% | -2,021.1% | -1,968.4% | -1,991.7% | -1,777.0% | -2,413.1% | -2,191.3% | -2,563.6% | -613.8% | 4.4% | -326.9% | -249.0% | -133.6% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.